| Name: | Dexamethasone Sodium Phosphate EP Impurity H |
| Catalogue No. | VE006241 |
| CAS No. | 162968-22-1 |
| Molecular Formula | C22H32FO8P |
| Molecular Weight | 474.46 |
| Status | In-stock |
| IUPAC Name | 9-fluoro-11B,17-dihydroxy-16a-methyl-3,20-dioxopregn-4-en-21-yl dihydrogen phosphate |
| Description | Dexamethasone Sodium Phosphate EP Impurity H (CAS No.: 162968-22-1) or 9-fluoro-11B,17-dihydroxy-16a-methyl-3,20-dioxopregn-4-en-21-yl dihydrogen phosphate is a metabolite of Dexamethasone which potent in lowering the overall incidence of vomiting and its influence on postoperative pain was minimal and helps in postoperative emesis. |
| References | Mousavi Nejad, Zohre, et al. “Synthesis, Physicochemical, Rheological and In-Vitro Characterization of Double-Crosslinked Hyaluronic Acid Hydrogels Containing Dexamethasone and PLGA/Dexamethasone Nanoparticles as Hybrid Systems for Specific Medical Applications.” International Journal of Biological Macromolecules, vol. 126, Apr. 2019, pp. 193–208,https://doi.org/10.1016/j.ijbiomac.2018.12.181.Liu, K., et al. “Effect of Dexamethasone on Postoperative Emesis and Pain.” British Journal of Anaesthe |
![(16α)-21-[(Ethoxycarbonyl)oxy]-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione](/public/site/files/site_images/thumb_16alpha-21-ethoxycarbonyl-oxy-17-hydroxy-16-methylpregna-1-4-9-11-triene-3-20-dione47031.png)
